Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strains.

MLA

Jean-Pierre, Vincent, et al. “Cefiderocol Susceptibility of Achromobacter Spp.: Study of an Accurately Identified Collection of 230 Strains.” Annals of Clinical Microbiology & Antimicrobials, vol. 23, no. 1, June 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12941-024-00709-z.

APA

Jean-Pierre, V., Sorlin, P., Pantel, A., Chiron, R., Lavigne, J.-P., Jeannot, K., Marchandin, H., Amara, M., Cadot, L., Dauwalder, O., Degand, N., Demar, M., Dupin, C., Fangous, M.-S., Franczak, C., Garnier, F., Guiet, P., Guinard, J., Hombrouck-Alet, C., & Kaoula, A. (2024). Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strains. Annals of Clinical Microbiology & Antimicrobials, 23(1), 1–13. https://doi.org/10.1186/s12941-024-00709-z

Chicago

Jean-Pierre, Vincent, Pauline Sorlin, Alix Pantel, Raphaël Chiron, Jean-Philippe Lavigne, Katy Jeannot, Hélène Marchandin, et al. 2024. “Cefiderocol Susceptibility of Achromobacter Spp.: Study of an Accurately Identified Collection of 230 Strains.” Annals of Clinical Microbiology & Antimicrobials 23 (1): 1–13. doi:10.1186/s12941-024-00709-z.